Novo Nordisk's 7.2 mg Wegovy injectable aims to enhance chronic weight management in adults with obesity, using an expedited ...

With the right technology and support, CRAs can continue their evolution into powerful agents of trial success that bridge ...

In today’s ACT Brief, we examine how AI and functional service partners are reshaping global pharmacovigilance, look at new ...

In today’s ACT Brief, we examine how AI is being integrated into administrative workflows at investigative sites, highlight the FDA’s approval of the first gene therapy for adolescents and adults with ...

The FDA has approved AstraZeneca’s Imfinzi (durvalumab) in combination with standard-of-care FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, and docetaxel) for the treatment of adult ...

Understand the regulatory and policy considerations for running clinical trial recruitment campaigns on nontraditional or ...

Explore methods to evaluate recruitment performance across multiple platforms, including engagement tracking, conversion ...

Learn how demographic and behavioral insights inform platform-specific messaging, creative formats, and call-to-action ...

The FDA has approved Novartis’ Itvisma (onasemnogene abeparvovec-brve) for the treatment of adolescents two years and older, teens, and adults living with spinal muscular atrophy (SMA) with a ...

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical ...

A new global Tufts CSDD survey of 387 investigative site professionals reveals broad experience with digital and decentralized trial tools, growing site-driven technology investments, and strong ...

In today’s ACT Brief, we examine declining site satisfaction and strategies to improve sponsor-site collaboration, review a new partnership enabling automated eSource-to-EDC data transfer, and ...